Fairfield, Bush & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fairfield, Bush & Co’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$270K	–	199
2017 Q4	$270K	Hold	5,000	–	–	0.07%	140
2017 Q3	$285K	Hold	5,000	–	–	0.09%	126
2017 Q2	$301K	Hold	5,000	–	–	0.1%	119
2017 Q1	$272K	Buy	+5,000	New	+$246K	0.08%	124

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fairfield, Bush & Co's BIVV Position: Q1 2018 in Review

Fairfield, Bush & Co sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,000 shares — an estimated $270K sold.

Fairfield, Bush & Co first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $301K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Fairfield, Bush & Co reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Fairfield, Bush & Co sold 5,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $270K.
Fairfield, Bush & Co first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Fairfield, Bush & Co's Bioverativ Inc. Common Stock position peaked at $301K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fairfield, Bush & Co's 13F filing for Q1 2018, filed 9 May 2018.